NOTE 6 — EQUITY

Common Stock

The Company has authorized 100,000,000 shares of common stock, $0.0001 par value. As of June 30, 2019 and December 31, 2018, 1,172,544 shares were issued and outstanding.

As of June 30, 2019 and December 31, 2018, the Company accrued liabilities of $3,300 for refunds that will be returned to prospective investors.

Stock Options

No options were granted during the six months ended June 30, 2019. A summary of the status of options granted as of June 30, 2019, and changes during the period then ended are as follows:

	For the Six Months Ended June 30, 2019
	Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value
Outstanding at January 1, 2019		35,000	$	1.50	1.25 years		$	—
Granted		-	$	-		-		—
Expired		5,000	$	1.50		-		—
Outstanding at June 30, 2019		30,000	$	1.50	0.88 years			—
Exercisable at June 30, 2019		30,000	$	1.50	0.88 years			—

The Company had 35,000 vested options at the beginning of the period. At June 30, 2019, the Company had 30,000 vested options with a weighted average exercise price of $1.50.

The total intrinsic value of options during the six months ended June 30, 2019 was $0. Intrinsic value is measured using the fair market value at the date of exercise (for shares exercised) or at June 30, 2019 (for outstanding options), less the applicable exercise price.